Percutaneous arterial embolization; Angiography; Gastrointestinal bleeding; Interventional imaging Abstract Purpose: The purpose of this study was to assess the safety and efficacy of transcatheter arterial embolization (TAE) in the treatment of acute lower gastrointestinal bleeding (LGIB) and to determine the potential factors that influence treatment outcome. Material and methods: A total of 38 patients with acute LGIB who were treated by TAE were retrospectively included. There were 24 men and 14 women, with a mean age of 61 years (range: 9-84 years). Patient characteristics, laboratory findings, treatments, causes of bleeding, angiographic findings, and outcomes were reviewed. Results: Active contrast extravasation was observed in 26/38 patients (68.4%) and was the most frequent angiographic finding, followed by abnormal mucosal staining (8/38; 21.1%) and tumor staining (4/38; 10.5%). Technical success of TAE was obtained in 35/38 patients (92%) whereas technical failure was observed in 3/38 patients (8%). Clinical success rate following TAE was 63%. Bowel ischemia occurred in 5/38 patients (13%) following TAE; mild ischemia without sequelae was observed in 3 patients and severe ischemias with bowel perforation requiring surgery in 2 patients. No variables were identified as significant predictive factors of failed TAE. Conclusion: TAE is a safe and effective treatment to control massive acute LGIB, especially in the emergency setting with a clinical success rate of 63%.
Acute gastrointestinal bleeding is an emergency condition that can lead to significant morbidity and mortality without prompt initiation of proper management [1] . Bleeding originating distal to the ligament of Treitz is defined as lower gastrointestinal bleeding (LGIB) [2] . The annual incidence of acute LGIB ranges from 20.5 to 27.0 per 100,000 adults in the general population and accounts for 1% to 2% of all hospital emergencies [1] .
Immediate proctosigmoidoscopy or colonoscopy is the initial examination of choice for the diagnosis and treatment of acute LGIB. However, in an emergency setting without bowel preparation, the definite or potential source of bleeding can be obscured by blood or fecal content, resulting in a high rate of non-diagnostic endoscopic examinations. In addition endoscopy conveys a risk of bowel perforation [3, 4] . When endoscopy is not feasible or after failed endoscopic management, transarterial embolization (TAE) is a relatively safe alternate option to emergency surgery [5] . The various pathologic causes of LGIB, the long length of the lower gastrointestinal tract, the often intermittent nature of LGIB, and the various embolic agents can complicate the angiographic evaluation and affect the treatment outcome of TAE [2, 6, 7] .
The aim of this study was to assess the safety and efficacy of TAE in the treatment of acute LGIB and to determine the potential factors that influence the treatment outcome.
Materials and methods

Patient population
We retrospectively evaluated the clinical records of all patients who underwent emergency TAE for acute LGIB from December 2007 to July 2015. A total of 86 patients who underwent mesenteric angiography for the evaluation of acute LGIB were initially identified. Of these, 47 patients (54.7%) with positive diagnostic angiography findings were subsequently treated with attempted therapeutic embolization. We excluded 9 of these 47 patients with missing data because of an unavailable admission history or loss of followup data after referral to another hospital. Institutional review board approved the study and informed consent was waived.
A total of 38 patients were included in the study. All patients had clinically active massive LGIB at the time of angiography and failed to respond to conservative medical therapy, were unable to undergo endoscopic treatment, or had continued bleeding despite endoscopic treatment. The study group comprised 24 men and 14 women, with a mean age of 61 years (range: 9-84 years). Fourteen patients (36.9%) had a normal coagulation status.
Clinical data and definitions
The following data were collected from the electronic medical records: patient demographics, laboratory findings, treatments, causes of bleeding and outcome data. Acute LGIB was defined as melena or bloody stool that began shortly before presentation (generally within 48 hours). Patients were considered hemodynamically unstable when they had hypotension (systolic blood pressure of < 90 mmHg) and tachycardia (heart rate of > 100/min) [8] . Blood loss was quantified by measuring the hemoglobin concentration and the amount of blood products transfused prior to embolization. If the patient required at least 4 units of blood within 24 hours, he was considered as having acute significant bleeding. Coagulopathy was diagnosed if one or more of the following criteria were present: international normalized ratio (INR) > 1.3, partial thromboplastin time > 33 seconds, or prothrombin time > 13.5 seconds. Thrombocytopenia was diagnosed when the platelet count was < 80,000/mm 3 . Preangiographic investigations involved endoscopy or radiographic studies performed after onset of acute LGIB episodes and within 7 days before the performance of TAE.
TAE methods and techniques
Selective angiographies were performed by one of six attending staff radiologists of our unit who had an experience in this field for at least 5 years or fellows under close supervision of the staff radiologist. The angiographic data were obtained from the original reports. We individually recorded the procedural data regarding the bleeding vascular territory, positive angiographic findings associated with the bleeding point, and number of arteries supplying the bleeding site.
Technical and clinical endpoints
Technical success was defined as the cessation of angiographic extravasation and/or the devascularization of flow in the supplying vessel and its branches of the bleeding site immediately after embolization based on angiographic findings ( Fig. 1) [8, 9] . Spontaneous cessation of bleeding as a result of arterial spasm during catheter navigation or failure of selective catheterization of the bleeding vessel that did not subsequently undergo embolization was considered as technical failure.
Clinical success was defined as resolution of signs and symptoms of bleeding, including a stable hemoglobin level and blood pressure, during the 30-day follow-up period after embolization. Clinical failure was defined as ongoing or recurrent active bleeding that required surgical intervention and/or death related to massive blood loss that occurred within 1 month after the angiographic procedure.
Complications
Complications following TAE were classified as non-specific or specific complications. Non-specific complications consisted of complications due to the angiographic procedure. Intestinal ischemia was a specific complication which was subsequently classified into mild and severe forms [8] .
Short-term follow-up
The final etiology of LGIB was determined from medical records, the results of imaging and endoscopic examinations, and all available histological and autopsy results. The incidence of persistent bleeding or early recurrent bleeding within 72 hours after TAE and the 30-day mortality rates were recorded. We also checked whether any patients required further intervention in the form of repeat TAE or surgery to stop the bleeding and whether any patients died of acute hemorrhage or hemorrhage-related complications.
Statistical analysis
The data were analyzed using STATA software Release 14.0 (StataCorp LP, College Station, TX, USA). Continuous variables were expressed as mean and range. Categorical variables were expressed as proportions and percentage. Technical success, clinical success, technical failure, and clinical failure were calculated as percentages. The potentially influential factors for technical success, clinical success, technical failure, clinical failure, and in-hospital mortality were searched for using univariate analysis. A Pvalue < 0.05 was considered statistically significant.
Results
Preangiographic investigations and cause of bleeding
Preangiographic investigations revealed evidence of active bleeding and/or the exact site of bleeding in 20/38 patients (52.6%). The most common positive investigation was endoscopy (8/38 patients; 21.1%). Computed tomography and red blood cell nuclear scans showed positive results in 6/38 patients each (15.8%). The most common etiologies of bleeding were diverticula and tumors (8/38 patients; 21.1% for each etiology). Other causes of LGIB and details of preangiographic investigations are listed in Table 1 .
Mesenteric angiography and embolization
A flow chart diagram of the patients is shown in Fig. 2 . Among the positive angiographic findings in the patients with acute LGIB, contrast extravasation was the most common finding in the present study (26/38; 68.4%) followed by abnormal mucosal staining (8/38; 21.1%) and tumor staining (4/38; 10.5%).
LGIB most commonly occurred in the superior mesenteric artery territory, which supplies the small bowel and right-sided colon (24/38; 63.2%). Multiple bleeding sites supplied by the jejunal branches of the superior mesenteric artery, ascending branch of the left colic artery, and inferior hemorrhoidal artery of the iliac artery, were identified in one patient who exhibited bleeding secondary to a coagulopathy. Most bleeding sites were supplied by one arterial branch (71.1%). Various embolic agents were used to occlude the corresponding arteries that supplied the bleeding sites. A single embolic agent was used in 33/38 patients (94.3%). Gelatin sponge was the most commonly used embolic agent in the present study (25/38; 71.4%), followed by polyvinyl alcohol particles (6/38; 17.1%) and microcoils (2/38; 5.7%). The details of the angiographic procedures and findings are described in Table 2 . Technical success of TAE was achieved in 35/38 patients (92%) whereas technical failure was observed in 3/38 patients (8%). The causes of technical failure included inability to perform superselective catheterization of the bleeding vessels (2/3 patients) and accidental vasospasm during catheterization (1/3 patient). The vasospasm resulted in the inability to perform superselective catheterization of the bleeding site and thus failure of embolization. Excluding the patient with accidental vasospasm, the patients with technical failure experienced ongoing bleeding. One of these two patients with persistent bleeding underwent surgery, but the bleeding failed to stop because of a coagulopathy and the patient died of massive blood loss. The other two patients with technical failure received medical treatment without the development of massive LGIB. However, one of these two patients died of acute respiratory distress syndrome within 30 days of hospitalization.
After exclusion of eight patients who died of causes unrelated to LGIB within 30 days of hospitalization (because clinical success of TAE was determined by the lack of recurrent bleeding for at least 30 days after TAE in this study), the clinical success rate was 63% (17/27 patients). Ten patients (26%) who developed recurrent bleeding were treated by surgery (n = 6), repeat transcatheter arterial embolization (n = 1), and conservative medical treatment with/without endoscopy (n = 3). Most of the causes of bleeding in the clinical failure group were benign (infection/inflammation, n = 3; coagulopathy, n = 1; diverticula, n = 1; and ulcer, n = 1). Malignant tumor was a cause of clinical failure in two patients. The remaining two patients had an inconclusive diagnosis.
Bowel ischemia in the embolization territory occurred in 5/38 patients (13%). Three patients had a mild degree of bowel ischemia detected by colonoscopy and underwent successful conservative treatment; one of these patients died of severe sepsis and disseminated intravascular coagulation unrelated to LGIB. The other two patients developed subsequent bowel perforations that required surgical intervention; one of these two patients died of sequelae of the bowel perforation. The patient who died was a 17-year-old woman patient with systemic lupus erythematosis, class IV lupus nephritis, and pathologically proven cytomegalovirus ileitis and colitis. She had clinical success following TAE for active bleeding from the ileocecal branch of the superior mesenteric artery. She developed a high-grade fever with newly detected pneumoperitoneum 20 days after TAE. Explorative laparotomy revealed necrosis and perforation at the terminal ileum, and small bowel resection with end-toend anastomosis was successfully performed. However, the patient died of Gram-negative septicemia 10 days later. The second patient with ischemic bowel perforation was an 81-year-old woman with small vessel disease and end stage renal disease being treated with hemodialysis; the etiology of LGIB was suspected to be a coagulopathy. TAE for multiple bleeding sites from the jejunal branches of the superior mesenteric artery and ascending branch of the left colic artery was technically successful, but embolization of the inferior hemorrhoidal artery failed because of the inability to perform superselective catheterization. Further colonoscopy with cauterization successfully stopped the rectal bleeding. Eight days later, she developed generalized 
Discussion
In the present study, the technical and clinical success rates of TAE following positive angiography for acute LGIB were 92% and 63%, respectively. This technical success rate can be considered satisfactory [9] . Technical failure in three patients was associated with difficult catheterization due to marked vascular tortuosity and vasospasm. Researchers have previously reported tortuosity and vasospasm as a cause of failed TAE [2, 10] . Other published causes of unsuccessful TAE, such as stenosis of the bleeding artery or difficulty in precise visualization of small arteries, were not observed in the present study.
In our study, the clinical success rate was slightly inferior to those in prior studies [11] [12] [13] [14] . This might be due to the exclusion of 8 patients without recurrent bleeding after TAE from calculation because of death unrelated to LGIB before 30 days; these patients had the potential to be included in the clinical success group. The other possible reason for our inferior clinical success rate may that nearly all patients with clinical failure (9 of 10 patients) were embolized with gelatin sponge, which is considered a temporary occlusive material that may be associated with subsequent recanalization and repeat bleeding. Gelatin sponge also requires intact coagulation to achieve vascular occlusion, while most of our patients had abnormal clotting parameters. In a coagulopathic condition, Takafumi et al. observed that glue or microcoils were more effective for hemostasis and prevention of recurrent bleeding than gelatin sponge [15] . However, Loffroy suggested that glue should be used by well-trained operator [7] .
In the present study, diverticula and tumors were the most common causes of bleeding. We did not observed patients with false aneurysm. However, Tétreau et al. reported that false aneurysms can be the cause of gastrointestinal bleeding in 17% of patients but are associated with a 91% success rate of TAE [6] . The role of TAE as a safe treatment option for patients with hemovolemic shock secondary to rupture splanchnic artery pseudoaneurysms has also been highlighted by other authors [16] .
Various types of embolic agents can be used for TAE depending on individual experience. Gelatin sponge is the most commonly used (71.0%) embolic material in an emergency setting because it is readily available, easy to use, and inexpensive. However, the absorbable property of gelatin sponge allows for future recanalization of embolized vessels; this probably explains the slightly higher rate of recurrent bleeding in our study (26%) by comparison with prior studies which mainly used permanent embolic agents (14.0%-21.4%) [11] [12] [13] [14] . However, no studies have reported the efficacy of gelatin sponge as an embolic agent for the treatment of acute LGIB. Kuo et al. reported a low rate of recurrent bleeding (14%, 3/22 patients) using microcoils for TAE in patients with LGIB [12] . These authors advocate microcoils as the embolic agent of choice for TAE in patients with LGIB because microcoils are highly radiopaque and can be more accurately deployed, do not induce particulate reflux, and decrease the perfusion pressure while allowing for adequate collateral flow, thus reducing the occurrence of infarction. The incidence of bowel ischemia following TAE varies from 0 to 25% [11] [12] [13] [14] . In the present ischemic complications were observed in 5/38 patients (13%). Three of these five patients had minor ischemia that was successfully resolved by conservative treatment without sequelae. The other two patients required surgical management of ischemic bowel perforation. Gelatin sponge was used as the embolic agent in 4/5 patients. Ramaswamy et al. found that small gelatin sponge particles can migrate distally in nearby collateral vessels, resulting in a higher risk of bowel ischemia [17] . While embolic agents are associated with a high risk of ischemic complications due to vessel occlusion, hypoperfusion and shock may also induce the development of bowel ischemia [18] . In the present study, 3/5 patients with ischemic complications, including the two with major bowel ischemia, also developed shock. Thus, it is possible that ischemia may develop from both occlusive and non-occlusive causes.
In our study no variables were significantly associated with failed TAE. Researchers have previously reported that coagulopathy and shock were associated with treatment failure in patients undergoing TAE [2, 19, 20] but such association was not confirmed by the results of our study. Other factors that have been reported as influencing treatment success (such as hemoglobin concentration < 8 g/dL, contrast extravasation, and more than one embolized vessel) did not reach statistical significance in the present study [2] . However, we observed a trend toward technical failure for TAE in the presence of comorbidities (OR, 0.12) and an INR > 1.3 (OR, 7.04) and a trend toward clinical failure for TAE in the presence of hypovolemic shock (OR, 5.00).
The overall in-hospital mortality rate was 31.5% consistent with those of prior studies ranging from 25.0 to 55.6% [11, 20, 21] . Most cases of in-hospital mortality after technical success of TAE (8/10 patients) were not related to LGIB but were a consequence of worsening of patients comorbidities. One of the three patients who experienced technical failure, which was secondary to unintentional vasospasm of the bleeding artery during catheterization, achieved complete hemostasis after the procedure and had no in-hospital rebleeding with concomitant medical treatment. This is similar to the catheter-induced vasospasm (CIV) technique described by Cynamon et al. [22] . They suggested that CIV may be a safe and effective method of embolizing known LGIB. Despite the unintentional vasospasm incurred during catheterization, our patient may be regarded as successfully treated and followed accordingly; this may have avoided the need for acute surgical therapy. However, CIV may be associated with a higher rate of rebleeding after follow-up and is not widely used.
Our study had some limitations, including its retrospective design and lack of randomization. Additionally, patients without angiographic evidence of LGIB were not included because of the undetermined exact location for embolization. Despite these limitations, the study represents a large single-center experience. However, further studies are needed with more patients are needed to clarify the specific variables that can predict treatment outcome.
In conclusion, TAE is an effective technique for the treatment of acute LGIB with a technical success rate of 92% for recurrent bleeding within 30 days of TAE. Despite the fact that TAE was associated with ischemic bowel complications in 13% of patients, most of such complications were minor, required no specific treatment, and had no sequelae.
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